Annual Total Liabilities
$5.15 M
-$1.69 M-24.65%
December 31, 2023
Summary
- As of February 26, 2025, CMMB annual total liabilities is $5.15 million, with the most recent change of -$1.69 million (-24.65%) on December 31, 2023.
- During the last 3 years, CMMB annual total liabilities has risen by +$3.48 million (+207.89%).
- CMMB annual total liabilities is now -24.65% below its all-time high of $6.84 million, reached on December 31, 2022.
Performance
CMMB Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$4.58 M
+$20.00 K+0.44%
September 1, 2024
Summary
- As of February 26, 2025, CMMB quarterly total liabilities is $4.58 million, with the most recent change of +$20.00 thousand (+0.44%) on September 1, 2024.
- Over the past year, CMMB quarterly total liabilities has increased by +$20.00 thousand (+0.44%).
- CMMB quarterly total liabilities is now -35.13% below its all-time high of $7.06 million, reached on March 31, 2023.
Performance
CMMB Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CMMB Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.6% | +0.4% |
| 3 y3 years | +207.9% | +0.4% |
| 5 y5 years | +207.9% | +0.4% |
CMMB Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.6% | +78.5% | -35.1% | +58.6% |
| 5 y | 5-year | -24.6% | +207.9% | -35.1% | +173.5% |
| alltime | all time | -24.6% | +207.9% | -35.1% | +173.5% |
Chemomab Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.58 M(+0.4%) |
| Jun 2024 | - | $4.56 M(-2.5%) |
| Mar 2024 | - | $4.68 M(-9.2%) |
| Dec 2023 | $5.15 M(-24.6%) | $5.15 M(-24.8%) |
| Jun 2023 | - | $6.86 M(-2.8%) |
| Mar 2023 | - | $7.06 M(+3.2%) |
| Dec 2022 | $6.84 M | $6.84 M(+22.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $5.59 M(+23.2%) |
| Jun 2022 | - | $4.54 M(+22.1%) |
| Mar 2022 | - | $3.72 M(+28.9%) |
| Dec 2021 | $2.89 M(+72.5%) | $2.89 M(+49.7%) |
| Sep 2021 | - | $1.93 M(-22.2%) |
| Jun 2021 | - | $2.48 M(-50.0%) |
| Mar 2021 | - | $4.96 M(+196.2%) |
| Dec 2020 | $1.67 M | $1.67 M |
FAQ
- What is Chemomab Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual total liabilities year-on-year change?
- What is Chemomab Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Chemomab Therapeutics?
- What is Chemomab Therapeutics quarterly total liabilities year-on-year change?
What is Chemomab Therapeutics annual total liabilities?
The current annual total liabilities of CMMB is $5.15 M
What is the all time high annual total liabilities for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual total liabilities is $6.84 M
What is Chemomab Therapeutics annual total liabilities year-on-year change?
Over the past year, CMMB annual total liabilities has changed by -$1.69 M (-24.65%)
What is Chemomab Therapeutics quarterly total liabilities?
The current quarterly total liabilities of CMMB is $4.58 M
What is the all time high quarterly total liabilities for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly total liabilities is $7.06 M
What is Chemomab Therapeutics quarterly total liabilities year-on-year change?
Over the past year, CMMB quarterly total liabilities has changed by +$20.00 K (+0.44%)